The options for treatment include surgery, radiation and chemotherapy--which are similar to oncology diseases. Primarily the goals are to maintain neurologic function and eliminate symptoms that many times are related to pain from compression on nerve. Radiation can help to limit pain but doesn't always restore the stability to the spine that surgery can. Most of the time the process is best treated by treating the primary tumor.

The standard treatments for brain tumors are surgery, radiation therapy, and chemotherapy. In some cases when the tumor is slow growing, the treatment team may delay surgery and use frequent scans to monitor the tumor's growth. Sometimes surgery alone will cure a brain tumor. In general, radiation and chemotherapy treatments are used as secondary or adjuvant treatments for tumors that cannot be managed using only surgery.

The primary treatment for these tumors is surgery. It is important for the doctor to keep checking for cancer cells left behind. The surgery ends when all cancer cells have been removed. This is called perioperative microscopic examination of surgical margins. If the tumor is large, cryotherapy (freezing of the tumor) may be needed. Researchers are also studying the use of chemotherapy eye drops for people who have conjunctival melanoma (and have tumors in several places on the eye).

These are rare tumors. They can be either primary tumors of the iris (e.g. malignant melanoma) or spread from another tumor (e.g. breast, lung). Treatment of these tumors depends on whether the tumor is growing and also whether there is any complication from the tumor (e.g. uncontrolled glaucoma). In the case of glaucoma that does not get better with medication, or if the tumor is growing quickly, it may be necessary to remove the entire eye.

Melanomas. The treatment for choroidal melanomas can include thermal destruction (cryotherapy or photocoagulation), radiation, local resection or complete removal of the eye, or no treatment at all (observation alone). The choice depends on the size of the tumor, on whether or not it is growing, and whether or not the person is having symptoms. All these options should be discussed in depth with the doctor, weighing all the risks and benefits of each choice. Nevus.

It depends on the type of tumor and how far it has invaded into the brain, as well as the patient's age and overall health. Three kinds of treatment are used: surgery (removing the tumor during an operation), radiation therapy (using high-dose x-rays/proton beams to kill tumor cells) and drug therapy to shrink and sometimes eradicate the tumor. Drugs can also block the pituitary gland from making too much hormone.

A tumor that starts growing in the brain is a primary brain tumor. These tumors may spread within the brain, but rarely travel to other sites in the body. Metastatic brain tumors are formed from cancer cells that originate in other parts of the body, and travel to the brain to form tumors. Cancers of the lung, breast, colon and melanoma often spread to the brain.

The number of tumors that can be treated is evaluated on an individual basis. Each patient's diagnosis and case is different.

Proper treatment depends upon the type and location of the specific tumor. Current treatments include surgery, radiation and chemotherapy. All sinus tumor cases are reviewed at our Tumor Board, where individual cases are reviewed in detail and discussed by specialists from ear, nose, and throat surgery, plastic surgery, radiation oncology, hematology oncology, radiology, pathology, prosthetics/reconstruction, speech pathology, and oral surgery.

For Malignant cancer, FUS can be used to treat of Breast and Liver cancers that showed the most promising results. Other types that can be treated are cancers of Kidney, Bone marrow and soft tissues. for Benign cancer, it can use for treatment of benign breast cancer and cancer of uterine fibroid for women.

RF ablation has been primarily used to treat liver tumors, either those that originate in the liver, such as hepatocellular carcinomas, or those that spread to the liver, such as metastatic disease. Studies are under way to determine the potential benefits of RFA as a treatment for a variety of cancers. In general, RFA is being tested for cancers that cannot be removed by surgeons because of their size or location, or because the patient is not healthy enough to have open surgery.

A metastatic tumor is a malignant cancer that started in another organ in the body and then separated and moved to another organ such as the brain. The most common brain cancer is metastatic. Up to 30% of patients with a diagnosis of cancer will develop a metastatic tumor. Some cancers have a preference or predilection to move to the brain. These include kidney, lung, skin (melanoma), and breast.

Metastatic kidney cancer is the most advanced form of kidney cancer. It occurs when the cancer has spread from the initial site in the kidney to other parts of the body, most often the lungs, liver and/or bones. Please see Facts About Kidney Cancer for more details.

Clinical trials for verifying the safety and efficacy of the MRgFUS technology (or ExAblate) are being conducted for, breast cancer, liver and bone tumors. For more information please check the InSightec website. ExAblate MR-guided Focused Ultrasound Treatment for uterine fibroids. © 2004-2008 All rights reserved.

Yes, and experience is accumulating in this area. Patient’s guardians should seek professional advice on specific cancers regarding DC therapy and carefully weigh their treatment options (See review)

This is because the amount of radiation required to kill a large tumor which fills most of the eye, is just too much for the eye to stand. Within months to years, many patients who are treated with radiation for very large ocular melanomas lose vision, develop glaucoma, or have their eye removed anyway. Despite these risks, many patients with large intraocular tumors can be treated with eye and vision-sparing radiation therapy.

Spine is a measure of the arrow's flexibility. Spine is frequently measured in pounds, but is not necessarily the same as a the draw weight of the bow. Usually spine is defined as the amount of weight which would have to be applied to the centre of a 26-inch length of arrow material to make it deviate by a half inch. This amount of spine is reckonned to be a good match to the draw weight of a modern recurve bow.

The term metastatic breast cancer indicates that the cancer has spread from the breast to other parts of the body such as bone, lung, liver, or brain.

Cancer is the growth of abnormal cells in the body. These extra cells grow together and form masses, or tumors. In colorectal cancer, these growths happen in the large intestine (colon and rectum). Cancers of the colon and the rectum are often talked about together as colorectal cancer because they have so much in common.

Herceptin has been studied in a large clinical trial in people with HER2-positive metastatic breast cancer. People participating in the clinical trial received either chemotherapy plus Herceptin or chemotherapy alone. A clinical trial is a test of a treatment to see if it is beneficial to a particular group of people. If a treatment works well in an extensive clinical trial, it may become a new therapy that can help many people with cancer.

Cancer that has spread from other areas in the body to the liver usually originated in the lung, breast, colon, pancreas, and stomach. Leukemia and other blood cancers sometimes also spread to the liver.

Lola, Utah, USA: Rarely is surgery the first line of treatment for women diagnosed with GTD. Generally, chemotherapy is recommended, and effective for remission and cure. In some cases of recurrent GTD, surgery or radiation may be recommended along with additional chemotherapy.

Neuroendocrine tumors of the pancreas (islet cell tumors) are much less common than tumors arising from the exocrine pancreas. Reports often indicate that there are about two to three thousand cases diagnosed in the U.S. each year - although autopsy indicates that there may be a higher incidence of these islet cell tumors than are diagnosed. About 75% of these tumors are "functioning.

The symptoms depend on the size of the tumor and the location. Symptoms are caused by damage to vital tissue and by pressure from the tumor or swelling, which may happen if the tumor blocks the flow of cerebrospinal fluid.

The causes of brain tumors are not known. Brain tumors are not contagious. They can occur at any age, although they are most common in children 3-12 years old and adults 40-70 years old. Risk factors include working in industries such as oil refining, rubber manufacturing and drug manufacturing; other studies show chemists and embalmers have higher incidence of brain tumors. Researchers also are looking at exposure to viruses as a possible cause.

There are primary and secondary brain tumors. Tumors that begin in brain tissue are known as primary tumors. Secondary tumors are when cancer spreads from another site to the brain, which is called metastasis. Brain tumors are classified by the type of tissue in which they begin. The most common brain tumors are gliomas. Astrocytomas arise from small, star-shaped cells called astrocytes. They may grow anywhere in the brain or spinal cord. In adults, astrocytomas most often arise in the cerebrum.

The doctor develops a treatment plan to fit each patient, depending on the patient’s age and general health and the type, location and size of the tumor. Brain tumors are treated with surgery, radiation therapy and chemotherapy. Before treatment most patients are given steroids to reduce swelling. They may also be given anticonvulsant medications to prevent seizures. Surgery is the usual treatment for most brain tumors. To remove the tumor, the neurosurgeon makes an opening in the skull.

We don't know because funding for benign brain tumor research is virtually nonexistent. That's about to change. In October 2002, Congress passed the Benign Brain Tumor Cancer Registries Amendment Act, which will force hospitals, clinics and doctors to report pituitary tumor incidence rates in the data collection of cancer registries. The problem remains diagnosis. No report of incidence rates is possible without it.